NEW YORK, Dec. 19, 2019 /PRNewswire/ -- Bernstein
Liebhard, a nationally acclaimed investor rights law firm,
announces that a securities class action has been filed on behalf
of investors that purchased or acquired the securities of Mylan
N.V. ("Mylan" or the "Company") (NASDAQ: MYL) between May 9, 2018 and May 6,
2019, inclusive (the "Class Period"). The lawsuit
filed in the United States
District Court for the Western District of Pennsylvania alleges violations of the
Securities Exchange Act of 1934.
If you purchased Mylan securities, and/or would like to
discuss your legal rights and options please visit Mylan
Shareholder Class Action or contact Matthew
E. Guarnero toll free at (877) 779-1414 or
MGuarnero@bernlieb.com.
The complaint filed in this class action alleges that throughout
the Class Period, Defendants made materially false and/or
misleading statements and/or failed to disclose that: (1) Mylan's
Morgantown facility was in
significant violation of the FDA's Current Good Manufacturing
Practice regulations; (2) Mylan would need to engage in a massive
restructuring and remediation program; (3) Mylan's North American
Segment would be substantially impacted by said program, which
would in turn materially impact Mylan's financial health; (3) Mylan
lacked effective internal control over financial reporting; and (4)
as a result of the foregoing, the Company's financial statements
were materially false and misleading at all relevant times.
The truth began to emerge with a series of disclosures (and
subsequent stock drops) beginning on August
8, 2018. Finally, on May 7,
2019, before the market opened, Mylan issued a press release
announcing the Company's financial and operating results for the
first fiscal quarter ended March 31,
2019. The press release disclosed, among other information,
that "North America segment net
sales ... [were] down 6% on an actual and constant currency basis,
primarily driven by changes in the competitive environment and the
impact of the Morgantown plant
remediation activities."
On this news, the price of the Company's common stock declined
$6.73, from a close on May 6, 2019 of $28.26 per share, to a close on May 7, 2019 of $21.53 per share, a drop of approximately 23.81
percent.
If you purchased MYL securities, and/or would like to discuss
your legal rights and options please visit
https://www.bernlieb.com/cases/mylannv-myl-shareholder-class-action-lawsuit-stock-fraud-234/apply
contact Matthew E. Guarnero toll
free at (877) 779-1414 or MGuarnero@bernlieb.com.
If you wish to serve as lead plaintiff, you must move the Court
no later than February 14, 2020. A
lead plaintiff is a representative party acting on behalf of other
class members in directing the litigation. Your ability to share in
any recovery doesn't require that you serve as lead plaintiff. If
you choose to take no action, you may remain an absent class
member.
Since 1993, Bernstein Liebhard LLP has recovered over
$3.5 billion for its clients. In
addition to representing individual investors, the Firm has been
retained by some of the largest public and private pension funds in
the country to monitor their assets and pursue litigation on their
behalf. As a result of its success litigating hundreds of lawsuits
and class actions, the Firm has been named to The National Law
Journal's "Plaintiffs' Hot List" thirteen times and listed in The
Legal 500 for ten consecutive years.
ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myl-investor-alert-bernstein-liebhard-llp-announces-the-filing-of-a-securities-class-action-against-mylan-nv-300977861.html
SOURCE Bernstein Liebhard LLP